« Return to News | Awards & Advancement

Plasticell wins R&D 100 award

Wednesday, June 29, 2011 12:44 PM

Plasticell, a biotechnology company specializing in high-throughput technologies for directed stem cell differentiation, has won the R&D 100 Award for its CombiCult v2.0 system.

The CombiCult platform is a high-throughput combinatorial screening technology that allows scientists to discover optimal stem cell differentiation protocols in record time, revolutionizing stem cell research and opening new avenues of discovery.

The introduction of CombiCult marked an advancement in stem cell R&D, as it targets a critical bottleneck in any stem cell research program—developing protocols that optimally direct stem cells to develop into a differentiated cell type of choice. The terminally differentiated cells have numerous applications in biomedical research and regenerative medicine.

Innovations in CombiCult 2.0, include a streamlined workflow with specially developed laboratory consumables and automation, and powerful proprietary bioinformatics software that result in marked improvements in speed and reliability compared to the first-generation platform. CombiCult has been deployed internally and by customers on a variety of adult and embryonic stem cells to generate a wide range of tissue types including blood, neuron, bone, cartilage, liver and heart.

The R&D 100Awards, also known as the “Oscars of Innovation,” is now in its 49th year and recognizes the 100 most technologically significant products of the year.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.